Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

OREX 1.61 -0.13 (-7.47%)
price chart
Orexigen Therapeutics Inc. (OREX) Drops 5.43% on February 08
Orexigen Therapeutics Inc. (OREX) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 5.43% to $1.74, a loss of $-0.0999 per share.
Orexigen Therapeutics, Inc. (NASDAQ:OREX) Growth Company
Zacks Research has specified a positive Growth Style score to Orexigen Therapeutics, Inc. (NASDAQ:OREX) by strong financial background and higher growth prospects.
Blame This for Orexigen Therapeutics, Inc.'s Mind-Numbingly Bad 2015
Shares of Orexigen Therapeutics (NASDAQ:OREX), a biotechnology company focused on the development of therapies to induce weight loss, collapsed 72% in 2015, based on data from S&P Capital IQ.
Orexigen Therapeutics, Inc.'s Stock Loses Weight on Downgrade
What: Orexigen Therapeutics (NASDAQ:OREX) ended the day down 8.6% after Wells Fargo downgraded its recommendation from an outperform rating to a market perform rating.
Analyst Downgrades: GoPro Inc, Gap Inc, and Orexigen Therapeutics, Inc.  Schaeffers Research (blog)
Weak On High Volume: Orexigen Therapeutics (OREX)  TheStreet.com
Why Orexigen Therapeutics, Inc.'s Stock Is Losing Weight Today
What: Orexigen Therapeutics' (NASDAQ:OREX) stock is down about 15% today after reporting earnings and updating investors on its plans after the bell yesterday.
3 NASDAQ Stocks See Falling Short Interest: Amazon.com, Inc. (AMZN), ARIAD ...  Wall Street Point
Orexigen Therapeutics, Inc. (OREX) Short Interest Update
Orexigen Therapeutics logo Orexigen Therapeutics, Inc. (NASDAQ:OREX) was the recipient of a large drop in short interest during the month of January.
Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker
Orexigen Therapeutics (NASDAQ:OREX) has been the darling of the obesity drugmakers, doing something Arena Pharmaceuticals (NASDAQ:ARNA) and VIVUS (NASDAQ:VVUS) weren't able to do: keep its share price above where it was when its ...
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More  Xconomy
Orexigen Therapeutics Inc. (OREX) Jumps 5.59% on February 04
Orexigen Therapeutics Inc. (OREX) was among the biggest gainers on the Russell 2000 for Thursday February 04 as the stock popped 5.59% to $1.89, representing a gain of $0.1 per share.
Cheyne Capital Management Has $298000 Stake in Orexigen Therapeutics, Inc. (OREX)
Orexigen Therapeutics logo Cheyne Capital Management continued to hold its position in Orexigen Therapeutics, Inc. (NASDAQ:OREX) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Stock to Track: Orexigen Therapeutics, Inc.
The shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) currently has mean rating of 2.38 while 1 analysts have recommended the shares as “BUY”, 4 recommended as “OUTPERFORM” and 2 recommended as “HOLD”.
EPS Forecast Of Orexigen Therapeutics, Inc. (NASDAQ:OREX)  Vanguard Tribune
Were Analysts Bullish Orexigen Therapeutics, Inc. (NASDAQ:OREX) This Week?  Sonoran Weekly Review